P
PLX//CIK 0001006281
Protalix BioTherapeutics, Inc.
Market Data
$3.06+$1.01 (+49.27%)
PLX · Last trade
Prev Close
$2.05
Range (30d)
$2.06 – $3.15
Recent Filings
- 8-K4.8 MBProtalix BioTherapeutics, Inc.Feb 11, 5:10 PM ET·0001104659-26-013498
- 8-K245.8 KBProtalix BioTherapeutics, Inc.Jan 30, 10:09 AM ET·0001104659-26-008410
- 8-K217.8 KBProtalix BioTherapeutics, Inc.Jan 5, 6:56 AM ET·0001104659-26-000393
- 10-Q6.5 MBProtalix BioTherapeutics, Inc.Nov 13, 6:58 AM ET·0001104659-25-110824
- 8-K389.8 KBProtalix BioTherapeutics, Inc.Nov 13, 6:54 AM ET·0001104659-25-110821
- 8-K213.4 KBProtalix BioTherapeutics, Inc.Nov 3, 4:44 PM ET·0001104659-25-105594
- 8-K4.4 MBProtalix BioTherapeutics, Inc.Oct 17, 8:08 AM ET·0001104659-25-100264
- 8-K234.6 KBProtalix BioTherapeutics, Inc.Aug 22, 4:39 PM ET·0001104659-25-081924
- 10-Q5.2 MBProtalix BioTherapeutics, Inc.Aug 14, 7:05 AM ET·0001558370-25-011471
- 8-K383.9 KBProtalix BioTherapeutics, Inc.Aug 14, 6:58 AM ET·0001558370-25-011468
Insiders
10- Akirov AlfredDirector
- Almon Einat BrillVP, Product Development
- Aviezer DavidDirector, President & CEO
- Bar-Shalev AmosDirector
- Bashan DrorDirector, PRESIDENT AND CEO
- Ben Zvi ShmuelDirector
- Boudes Pol FDirector
- Bronfeld ZeevDirector, 10% Owner
- Camber Capital Management LP10% Owner
- Dexcel Pharma Technologies Ltd.10% Owner
Tickers
Addresses
business
2 UNIVERSITY PLAZA SUITE 100
HACKENSACK, NJ, 07601
mailing
2 UNIVERSITY PLAZA SUITE 100
HACKENSACK, NJ, 07601
Former Names
- ORTHODONTIX INC2007-02-22
- EMBASSY ACQUISITION CORP1998-03-31